vs
高乐氏（CLX）与芝商所（CME）财务数据对比。点击上方公司名可切换其他公司
芝商所的季度营收约是高乐氏的1.1倍（$1.9B vs $1.7B），高乐氏净利率更高（9.4% vs 0.1%，领先9.3%），芝商所同比增速更快（14.5% vs 0.3%），过去两年芝商所的营收复合增速更高（10.8% vs -8.3%）
高乐氏是美国跨国企业，专业从事消费级与专业用途产品的生产及营销。2000年至2024年持续入选《财富》500强榜单，最新排名为第485位，旗下产品覆盖清洁护理、家居日用等多个品类，在全球消费市场拥有较高认可度。
芝商所是总部位于美国伊利诺伊州芝加哥的金融服务企业，为全球规模最大的金融衍生品交易所运营商，旗下拥有芝加哥商品交易所、芝加哥期货交易所、纽约商业交易所、纽约商品交易所等交易平台，覆盖农产品、货币、能源等品类交易，同时持有标普道琼斯指数27%的股权。
CLX vs CME — 直观对比
营收规模更大
CME
是对方的1.1倍
$1.7B
营收增速更快
CME
高出14.2%
0.3%
净利率更高
CLX
高出9.3%
0.1%
两年增速更快
CME
近两年复合增速
-8.3%
损益表 — Q2 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.7B | $1.9B |
| 净利润 | $157.0M | $1.2M |
| 毛利率 | 43.2% | — |
| 营业利润率 | — | 0.1% |
| 净利率 | 9.4% | 0.1% |
| 营收同比 | 0.3% | 14.5% |
| 净利润同比 | -15.6% | 20.7% |
| 每股收益（稀释后） | $1.29 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLXCME
| Q1 26 | — | $1.9B | ||
| Q4 25 | $1.7B | $1.6B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | $2.0B | $1.7B | ||
| Q1 25 | $1.7B | $1.6B | ||
| Q4 24 | $1.7B | $1.5B | ||
| Q3 24 | $1.8B | $1.6B | ||
| Q2 24 | $1.9B | $1.5B |
净利润CLXCME
| Q1 26 | — | $1.2M | ||
| Q4 25 | $157.0M | $1.2B | ||
| Q3 25 | — | $908.0M | ||
| Q2 25 | $332.0M | $1.0B | ||
| Q1 25 | $186.0M | $956.2M | ||
| Q4 24 | $193.0M | $874.6M | ||
| Q3 24 | $99.0M | $912.8M | ||
| Q2 24 | $216.0M | $883.2M |
毛利率CLXCME
| Q1 26 | — | — | ||
| Q4 25 | 43.2% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 46.5% | — | ||
| Q1 25 | 44.6% | — | ||
| Q4 24 | 43.8% | — | ||
| Q3 24 | 45.8% | — | ||
| Q2 24 | 46.5% | — |
营业利润率CLXCME
| Q1 26 | — | 0.1% | ||
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 63.3% | ||
| Q2 25 | 20.6% | 66.7% | ||
| Q1 25 | 15.2% | 67.5% | ||
| Q4 24 | 14.1% | 62.1% | ||
| Q3 24 | 10.0% | 64.6% | ||
| Q2 24 | 14.5% | 65.3% |
净利率CLXCME
| Q1 26 | — | 0.1% | ||
| Q4 25 | 9.4% | 71.7% | ||
| Q3 25 | — | 59.1% | ||
| Q2 25 | 16.7% | 60.6% | ||
| Q1 25 | 11.2% | 58.2% | ||
| Q4 24 | 11.4% | 57.3% | ||
| Q3 24 | 5.6% | 57.6% | ||
| Q2 24 | 11.4% | 57.6% |
每股收益（稀释后）CLXCME
| Q1 26 | — | — | ||
| Q4 25 | $1.29 | $3.24 | ||
| Q3 25 | — | $2.49 | ||
| Q2 25 | $2.68 | $2.81 | ||
| Q1 25 | $1.50 | $2.62 | ||
| Q4 24 | $1.54 | $2.40 | ||
| Q3 24 | $0.80 | $2.50 | ||
| Q2 24 | $1.74 | $2.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $227.0M | $2.4B |
| 总债务越低越好 | — | $3.4B |
| 股东权益账面价值 | $-125.0M | — |
| 总资产 | $5.6B | $202.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CLXCME
| Q1 26 | — | $2.4B | ||
| Q4 25 | $227.0M | $4.5B | ||
| Q3 25 | — | $2.6B | ||
| Q2 25 | $167.0M | $2.1B | ||
| Q1 25 | $226.0M | $1.5B | ||
| Q4 24 | $290.0M | $3.0B | ||
| Q3 24 | $278.0M | $2.4B | ||
| Q2 24 | $202.0M | $1.9B |
总债务CLXCME
| Q1 26 | — | $3.4B | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $2.5B | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $2.5B | — |
股东权益CLXCME
| Q1 26 | — | — | ||
| Q4 25 | $-125.0M | $28.7B | ||
| Q3 25 | — | $28.2B | ||
| Q2 25 | $321.0M | $27.7B | ||
| Q1 25 | $27.0M | $27.0B | ||
| Q4 24 | $-41.0M | $26.5B | ||
| Q3 24 | $60.0M | $28.2B | ||
| Q2 24 | $328.0M | $27.6B |
总资产CLXCME
| Q1 26 | — | $202.0B | ||
| Q4 25 | $5.6B | $198.4B | ||
| Q3 25 | — | $187.1B | ||
| Q2 25 | $5.6B | $179.9B | ||
| Q1 25 | $5.5B | $157.8B | ||
| Q4 24 | $5.6B | $137.4B | ||
| Q3 24 | $5.5B | $137.8B | ||
| Q2 24 | $5.8B | $123.4B |
负债/权益比CLXCME
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 7.74× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 7.56× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLX
| Health And Wellness | $643.0M | 38% |
| Household | $419.0M | 25% |
| Lifestyle | $321.0M | 19% |
| Other | $290.0M | 17% |
CME
暂无分部数据
